Background: Enteric microbiota is increasingly being recognized as an important factor in the pathogenesis of irritable bowel syndrome (IBS). The reported prevalence of small intestinal bacterial overgrowth (SIBO) in subjects with IBS is highly variable, and there is no consensus on the role of SIBO in different subtypes of IBS, and indications and methods of testing.
Methods: A comprehensive literature search was performed for studies applying tests for SIBO in subjects with IBS. After applying prospectively decided exclusion criteria, the eligible papers were examined using a meta-analysis approach for the prevalence of SIBO in subjects with IBS using different tests. The odds ratios of SIBO among subjects with IBS as compared with healthy controls using different tests were calculated.
Results: Of the available studies (22, 17, 5, and 3 using lactulose and glucose hydrogen breath tests [LHBT and GHBT], jejunal aspirate culture, and more than one tests, respectively) meeting the inclusion criteria, 36.7% (95% confidence interval [CI] 24.2-44.6) had a positive test for SIBO. Patients with IBS were 2.6 (95% CI 1.3-6.9) and 8.3 (95% CI 3.0-5.9) times more likely to have a positive test for SIBO as compared with healthy controls using GHBT and jejunal aspirate culture, respectively. Patients with diarrhea-predominant IBS were more likely to have positive GHBT as compared with the other subtypes.
Conclusions: Patients with IBS were more likely to have SIBO as compared with healthy subjects using GHBT and jejunal aspirate culture but not using LHBT. Patients with diarrhea-predominant IBS more often have SIBO.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/jgh.14938 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rifaximin-Alpha Increases Lactase Activity in Patients with Irritable Bowel Syndrome Without Constipation and Small Intestinal Bacterial Overgrowth.
Dig Dis Sci
December 2024
Gastrointestinal Motility Laboratory, Department of Gastroenterology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico D.F., Mexico.
Background: Irritable bowel syndrome symptoms are associated with diverse pathophysiological mechanisms including small intestinal bacterial overgrowth and food intolerance. Small intestinal bacterial overgrowth leads to the decreased activity of several digestive enzymes, including lactase.
Aims: To assess the efficacy of rifaximin-alpha on the symptoms and lactase activity of patients with irritable bowel syndrome without constipation.
Evaluation of a Novel Smart Capsule Bacterial Detection System Device for Diagnosis of Small Intestinal Bacterial Overgrowth.
Neurogastroenterol Motil
November 2024
Medical College of Georgia, Augusta University, Augusta, Georgia.
Background: There is a large unmet need for alternative, non-invasive, and accurate diagnosis of small intestinal bacterial overgrowth (SIBO). The smart capsule bacterial detection system (SCBDS) device contains a targeted sampling technology and an onboard SCBDS assay to detect metabolically active bacteria in the small intestine. Here, we evaluated the agreement of SCBDS assay with duodenal aspiration/culture ex vivo in a multicenter clinical study.
View Article and Find Full Text PDFEvaluation of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Subjects With Rosacea.
Cureus
October 2024
Dermatology, University of Michigan, Ann Arbor, USA.
Article Synopsis
- Systemic immune system abnormalities may play a role in rosacea development, with studies indicating a higher presence of abnormal bacteria and small intestinal bacterial overgrowth (SIBO) in affected individuals, though inconsistent testing has led to discrepancies in findings.* -
- This study aimed to accurately assess the prevalence of abnormal bacteria and SIBO in individuals with rosacea while controlling for potential confounding factors, excluding those with gastrointestinal diseases or significant health issues.* -
- Findings showed that 14.8% tested positive for abnormal bacteria and 33.3% for SIBO, with a notably higher SIBO rate in the rosacea cohort compared to the general population, suggesting a possible link between SIBO and ros
Small Bowel Diverticulosis in an Elderly Patient Presenting With Obstruction and Intestinal Dysmotility: A Case Report.
Cureus
October 2024
Department of Surgery, University of South Florida Morsani College of Medicine, Tampa, USA.
Small bowel diverticulosis can occur anywhere in the small bowel but is most common in the duodenum. Jejunoileal diverticulosis is much less common and tends to have a more chronic, nonspecific disease course. In the literature, this condition has a higher incidence in men in their sixth and seventh decades of life.
View Article and Find Full Text PDFAssociation between small intestine bacterial overgrowth and psychiatric disorders.
Front Endocrinol (Lausanne)
November 2024
Department of Physiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Zabrze, Poland.
Article Synopsis
- Small intestinal bacterial overgrowth (SIBO) is a condition where an abnormal number of bacteria grow in the small intestine, potentially leading to various gastrointestinal and mental health issues.
- There is limited understanding of how SIBO affects tryptophan metabolism and its connection to psychiatric disorders such as autism, schizophrenia, and Alzheimer’s disease.
- The analysis of literature stresses the need for more comprehensive studies to better understand the links between SIBO, gut health, and mental health, proposing a combined treatment approach for complex psychiatric conditions.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!